HUMA
Humacyte
$0.47
+$0.02 (+5.38%)Oct 28, 2026
Key metrics
The numbers that frame HUMA today
- Market cap
- $130.57M
- Gross margin
- -494.6%
- EV / Sales
- 55.0
- ROIC
- -80.5%
- Div yield
- 0%
- Debt / equity
- 2.1
- 52wk Low
- $0.34
- 52wk High
- $1.78
Growth
Revenue and earnings trend for HUMA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about HUMA
Is Humacyte a good buy?
No. Humacyte has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Humacyte is selling at a very high price.
What is the market capitalization of HUMA?
Humacyte's market capitalization is $130.57M.
What is the 52-week high for HUMA stock?
The 52-week high for Humacyte is $1.78. The current close of $0.47 is 73.6% below that high.
What is the 52-week low for HUMA stock?
The 52-week low for Humacyte is $0.34. The current close of $0.47 is 39.5% above that low.
Does HUMA stock pay dividends?
Humacyte does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for HUMA?
Humacyte's Debt / Equity ratio is 2.12.